Forbes April 11, 2024
John LaMattina

In the spring of 2020, Covid-19 essentially shut down the U.S. as well as most of the rest of the world. It was terrifying to hear the news reports of hospitals being overwhelmed with those suffering from the virus and seeing tragic pictures of refrigerator trucks filled with those who succumbed. It was hard to envision how the world was going to survive the pandemic.

Millions died across the globe. Yet, we ultimately survived thanks to the efforts of the biopharmaceutical industry. Vaccines from Moderna and BioNTech/Pfizer were miraculously discovered and developed in record time with vaccines being administered to healthcare personnel by December 2020. But other companies such as J&J, Sanofi/GSK, AstraZeneca, and Novavax also were eventually successful with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma, Pharma / Biotech, Public Health / COVID
Pepper Bio spices up pipeline with $135M deal for G1 Therapeutics' CDK4/6 inhibitor
BIO survey to elucidate US biopharma's reliance on Chinese CDMOs amid decoupling threats
Lilly uses Mounjaro millions to hunt for biotech partners
FTC cracks down on drug patents
Methods To Alter Cellular Gene Expression

Share This Article